OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Cardiac Failure is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management	434
JCF Heart Failure Year-In-Review 2023… Shaping the Future of Heart Failure	280
Table of Contents	127
Measuring Clinically Important Changes in Patients With Heart Failure	124
Echocardiographic Variables Predict Outcome In Children, Adolescents, And Adults With Barth Syndrome: A Longitudinal Observational Study	113
Identifying Barriers To SGLT2 Inhibitor Use In Eligible Patients With Heart Failure: A Real-world Experience From A Single Centre	106
Predicting Cardiac Structural And Functional Improvement On Left Ventricular Assist Device Support: The Externally Validated UCAR Score	101
Utilizing The Electronic Medical Record To Assess Optimal Medical Therapy In Heart Failure Patients	77
No Competition, No Progress	75
A Distinction Between Wellness and Resilience	74
Hospitalization For Acute Kidney Injury In Patients With Heart Failure & Atrial Fibrillation Is Associated With Greater Risk Of Cardiogenic Shock & Major Adverse Cardiovascular Outcomes	72
Differences In Lung Fluid Quality Between Decompensated Heart Failure Patients And Covid-19 Patients- Results Of The Impedance-corona Trial	62
Symptomatic Heart Failure With Preserved Ejection Fraction: Is It Too Late to Consider Additional Therapies?	55
Candidacy For Transcatheter Edge-to-edge Mitral Valve Repair Despite Low Cardiac Index A Single Center Experience	55
Non-invasive Assessment Of Elevated Left Ventricular End Diastolic Pressure Using A Small Portable Device: Design For Tele-Monitoring	54
Clinicians’ Practices In Pain Assessment And Management For Elderly With Heart Failure	53
Younger Adults Have Discordant Heart Failure Symptoms	51
Outcomes Of Hospitalization In Patients With Diastolic Heart Failure Undergoing Hematopoietic Stem Cell Transplant (HSCT): A National Inpatient Sample Analysis (2002-2019)	49
Efficacy And Safety Of Intravenous Iron In Patients With Iron Deficiency Anemia And Heart Failure With Reduced Ejection Fraction. A Systematic Review And Meta-analysis	48
Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization	48
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions	43
Proteomic Correlates Of Urinary Protein Creatinine Ratio In Heart Failure With Preserved Ejection Fraction	43
Psoas Muscle Index As An Independent Risk Factor Predictive Of Increased Post Operative Length Of Stay In Orthotopic Heart Transplant Candidates	42
Prognostic Value Of Percentage Of Predicted Peak Oxygen Consumption Using Functional Aerobic Impairment And Friend Equations In Patients With Heart Failure With Reduced Ejection Fraction	42
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial	42

Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort	41
Readmission Rate And Hospitalization Costs In HFpEF In Patients With OSA	39
Methodological Quality Of Clinical Practice Guidelines In Heart Failure: A Systematic Critical Appraisal Using The Agree II Tool	38
A Resident-led Initiative To Improve Heart Failure Readmission Rate By Targeting Factors Of Social Vulnerability	37
Synchronized Diaphragmatic Stimulation As A Potential Outpatient Implant Procedure For HfrEF Therapy	37
Masthead	36
Circulating Metabolomic Profile Predicts Change In Ejection Fraction In Heart Failure Patients	36
The Swan is not the Ugly Duckling	35
Durable Mechanical Circulatory Support: The Spring of Hope or the Winter of Despair?	35
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in “Negative” Clinical Trials	35
Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock	35
From Inflammation to Inspiration and Innovation: A New Perspective on the Utility of Anti-inflammatory Therapies for Acute Heart Failure	34
JCF in Case you Missed it! ESC Heart Failure Congress 2025	33
Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis	32
Higher ECMO Flow Index And Hyperoxia Are Associated With Increased Mortality In Adults With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: An ELSO Registry Analysis	31
Development And Implementation Of An Rv Stress Test To Assess Rv Reserve Pre-lvad	30
Bridging The Ep & Hf Gap: A Dual Aprn Model Can Optimize Post-crt Management.	30
Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF	30
Effectiveness Of A Virtual Patient Simulation At Improving Diagnosis And Treatment Of Cardiac Amyloidosis	29
Atrial Fibrillation Ablation for Patients with Heart Failure	29
PHOSPHOPROTEOMIC INSIGHTS INTO PATHOBIOLOGY AND POTENTIAL DRUG TARGETS IN A PORCINE MODEL OF EXPERIMENTALLY INDUCED PULMONARY VENOUS HYPERTENSION	28
QT Interval Correction In Left Bundle Branch Areas Pacing (LBBAP)	28
Outcomes In Patients With Right Ventricular Failure & Preserved Left Ventricular Systolic Function On Short-term Inotropic Support	28
Cardiovascular Interplay Between Heart Failure Patients With Concurrent Depression, A Comprehensive Retrospective Analysis	28
Breaking Prescription Patterns: The Persistent Challenge of Guideline-directed Medical Therapy Underuse	27
Emerging Adults: a Group Caught in the Middle	27
Ventricular Assisted Device In Transposition Of Great Arteries: Indications, Outcomes, Hemodynamic Insights	27
Urinary Sodium-Guided Intravenous Diuretic Therapy in Acute Heart Failure: Transitioning From Art to Science?	27
Cardiac Magnetic Resonance In Patients With Suspectedtachycardia-induced Cardiomyopathy - The Impact Of Lategadolinium Enhancement And Epicardial Fat Tissue	27
Delay In Door-to-diuretic Time Is Associated With Greater Odds Of 30-day Readmission And Mortality	27
Association Of Amiodarone With Rvf Post Lvad	27
Poor Medication Access as a Driver of Excess Heart-Failure Readmissions Among Patients Living in Economically Deprived Neighborhoods	26
Heart Failure in Latin American Women: A Call for Action	25
Functional Status at Time of Palliative Care Consult and Decision-Making Capacity Among Patients Hospitalized With Heart Failure	25
Novel FIRE1 Inferior Vena Cava Sensor Effective In Tracking And Managing Fluid Shifts In A Heart Failure Patient	24
Towards Improved Patient-Centered Communication in High-Stakes Heart Failure Decisions: the “Best Case/Worst Case” Framework	24
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial	23
Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clin	23
Biomarker Testing Considerations in the Evaluation and Management of Patients With Heart Failure: Perspectives From the International Federation of Clinical Chemistry and Laboratory Medicine Committee	23
The Hemodynamic Obesity Paradox: Decoupling of Hemodynamics and Congestive Symptoms in Patients with Heart Failure and Obesity	23
Evolving Training Paradigms: The Critical Need for Advanced Heart Failure in the Contemporary CICU	22
Improving ATTR-CM Detection: Targeting Populations With the Greatest Need	22
Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review	22
Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?	22
Clinical Outcomes of Chronic Intravenous Inotropic Support in Cardiac Amyloidosis	21
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America	21
The Impact Of Altitude Changes On CardioMEMS Readings	21
Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States	21
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary	20
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials	20

The Interaction Between Patient Activation And Patient-clinician Relationship Quality: Implications For Ambulatory Heart Failure Care	20
Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry	20
Body Mass Index And Natriuretic Peptides Trends Before And After Left Ventricular Assist Device: Evidence That Gains In Body Mass Follow On Resolution Of Heart Failure	20
Cardiovascular Medication Use And Timing Of Incident Heart Failure In Patients With Systemic Autoimmune Rheumatic Diseases: A Single-Center Experience	20
Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure	20
Doxycycline For Chronic Driveline Infections Can Cause Diabetes Insipidus	20
Pulmonary Capillary Recruitment Is Attenuated Post Left Ventricular Assist Device Implantation	20
Clinical Characteristics And Outcomes Associated With Atrial Fibrillation And Rapid Ventricular Response In Decompensated Heart Failure With Preserved Ejection Fraction	19
Impact Of Potassium Abnormalities On In-hospital Chf Outcomes: A Nationwide Perspective	19
Barriers To ARNi Prescribing By Internal Medicine Residency Program Trainees Of A Single Academic Center	19
Utilization Of Palliative Care In Patients Undergoing Extracorporeal Membrane Oxygenation: A National Perspective On Disparities And Outcomes	19
Impact Of Cardiac Contractility Optimizer On Echocardiographic Parameters In Chronic Heart Failure	19
Females Have Lower Acute Heart Failure Compared To Males In Patients Who Undergo Catheter Ablation For Atrial Fibrillation: A Nationwide Analysis	19
Impact Of Digital Health Interventions In The Quality Of Life Of Patients With Heart Failure: A Randomized Trial	19
Presentation Traits Of Vaccinated Versus Unvaccinated Heart Failure Patients At Acute Covid-19 Hospitalization	18
Outcomes Of Transcatheter Aortic Valve Implantation For Aortic Insufficiency In Left Ventricular Assist Device Patients	18
Myocarditis Following Covid-19 Vaccination In Adolescents And Adults In 2021	18
Using Objective Electrocardiographic Data To Better Predict Mortality In Patients Hospitalized With COVID-19	18
Atrial Fibrillation And Conduction Disease Are Associated With Cardiac Amyloidosis Subtypes	18
Non-contact Molecular Chemical Imaging For Evaluation Of Lower Extremity Congestion: A Validation Study Compared To MRI	18
Cystatin C Versus Creatinine-Based Assessment Of Kidney Function In Patients With Heart Failure And Reduced Ejection Fraction: Insights From PARADIGM-HF	18
Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF	17
In-hospital Outcomes Of Patients With Systemic Sclerosis Admitted For Heart Failure: An Analysis Of The National Inpatient Sample	17
Crosstalk Between Apolipoprotein M And Inflammation In Right Heart Failure	17
Lower Diastolic Blood Pressure Is A Predictor Of Delayed Diuretic Time	17
Impact Of Dapagliflozin Treatment On Serum Sodium Concentration In Acute Decompensated Heart Failure	17
Mechanical Circulatory Support And Cerebral Perfusion In Patients With Heart Failure	17
Hemodynamic-guided Management Of Heart Failure Patients With Implantable Pulmonary Pressure Monitoring: A Single Center Experience.	17
Editorial Board	16
Synergy, not Silos: The Intersection of Medical and Surgical Training in Advanced Heart Failure	16
Is Simpler Better? The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Cardiomyopathy	16
Apical Sparing Strain Imaging In Patients With Hypertensive Emergency: A Study Of Patients Characteristics And Prognostic Value	16
Von Willebrand Factor Activation Assays Predict Bleeding And Other Hemocompatibility-Related Adverse Events In Patients With CF-LVAD.	16
Genetic Testing for Cardiomyopathies in Japan: Embarking on a Journey of Discovery	16
Association Between Participation in a Heart Failure Telemonitoring Program and Health Care Utilization and Death Within an Integrated Health Care Delivery System	16
Role of Internal Jugular Venous Ultrasound in suspected or confirmed Heart Failure: A Systematic Review	16
Role and Contribution of the General Heart Failure Cardiologist: Further Expansion of the Multidisciplinary Heart Failure Approach	15
Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure	15
Cardiac Transplantation Trends And Outcomes Among Hispanic Patients	15
Table of Contents	15
Phenotypes of Peril: The Hidden Burden of End-Organ Failure in Cardiogenic Shock	15
Genetic Referral Patterns and Outcomes Among Patients With Nonischemic Cardiomyopathy Requiring Advanced Therapies	15
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support	15
Temporal Trends In The Incidence And Prevalence Of Transthyretin Amyloid Cardiomyopathy In The USA: An Observational Database Study	14
Remote Monitoring And Population Health Collaboration For Improving Heart Failure Outcomes	14
Divergent Trends in Emergency Department Presentations Amid the Novel Coronavirus Disease 2019 Pandemic in Chicago, Illinois	14
Impact Of Sarcopenic Obesity On Outcomes Following Acute Decompensated Heart Failure Hospitalization	14
Heart Failure Functional Class And Diuretic Dosage Are Associated With Mortality In Patients With AL Cardiac Amyloidosis	14
Cardiovascular Outcomes In Pregnant Women With Ventricular Septal Defect: A National Inpatient Database Analysis	14
Biology or Disparity? Untangling Racial Differences in Val122Ile Transthyretin Cardiac Amyloidosis	14
Prevalence Of Clinically Recognized Phenotypes In Advanced Heart Failure	14
Fatty Livers And Fragile Hearts - Unveiling Mortality Risks From Nonalcoholic Fatty Liver Disease In Patients With Cardiogenic Shock	14
Efficacy Of Vasodilators On Hemodynamics For Pulmonary Hypertension Patients Undergoing Mitral Valve Replacement Surgery: A Systematic Review And Network Meta-analysis	14
Masthead	14
Comparing Outcomes Among Patients With Ischemic Cardiomyopathy Versus Nonischemic Cardiomyopathy Who Had A Cardiac Arrest: A Nationwide Retrospective Observational Study	13
Comparison Of Two Different Methods For Clustering SCG Signals	13
Predictors And Longitudinal Change In Left Ventricular Ejection Fraction Among Patients With Cardiomyopathy Undergoing Atrial Fibrillation Ablation	13
Five-Year Readmission Trends, Burden, And Outcome Of Transcatheter Aortic Valve Replacement With Heart Failure	13
Incidence Of Ventricular Tachycardia And Fibrillation Detected By An Insertable Cardiac Monitor In Patients With Symptomatic Heart Failure With Reduced And Preserved Ejection Fraction	13
Cardiac Biomarkers In Amyloidosis Predict Small Intestinal Bacterial Overgrowth	13
Pre-operative Optimization Of Pheochromocytoma	13
Impact Of Atrial Fibrillation On Outcomes Of Congestive Heart Failure Patients With Hyponatremia - National Inpatient Sample Analysis	13
Incidence And Predictors Of Recurrent Pericarditis In A Longitudinal Lupus Cohort	13
Reversible Apical Hypertrophic Cardiomyopathy: A Case Series	13
Sotagliflozin Reduces The Risk Of Cardiovascular Events In Patients With Left Ventricular Hypertrophy Without Hypertension: A Post Hoc Analysis From SCORED	13
Pathogenic Transthyretin Gene Mutations In Phenotypic Hypertrophic Cardiomyopathy: An Underrecognized Double Whammy	13
Electrical Dyssynchrony in Cardiac Amyloidosis: Prevalence, Predictors, Clinical Correlates, and Outcomes	12
Anomalous Origin Of The Right Coronary Artery With A Malignant Course Between The Pulmonary Artery And Aorta	12
Carcinoid Heart Disease- A Presentation Of The Recurrent Metastatic Neuroendocrine Tumor Of Small Intestine	12
Comparison Of Pharmacist-directed And Protocol-driven Warfarin Management In Ambulatory Patients With Left Ventricular Assist Device	12
Cardiac And Kidney Benefits Of Dapagliflozin Are Associated With ApoM Levels In Patients With Heart Failure With Reduced Ejection Fraction	12
With Great Data Come Great Responsibilities: The Cardiac Amyloidosis Registry Study	12
Not To Be Forgotten: Implications Of Right Ventricular Inflammation On Positron Emission Tomography In Cardiac Sarcoidosis	12
Table of Contents	12
The Great Asian Mismatch: Training Versus Care in Heart Failure	11
Medically Tailored Meals in Heart Failure: A Systematic Review of the Literature, 2013-2023	11
Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)	11
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry	11
Right Heart Dysfunction and Readmission Risk Across Left Ventricular Ejection Fraction Status in Patients With Acute Heart Failure	11
Cardiac Transplantation in Danon Disease	11

Impact Of Sodium Derangements In Patients Hospitalized With Atrial Fibrillation Without Heart Failure: A Nationwide Cohort Study	11
Evolving Paradigms and Future Frontiers In Heart Transplantation in the Modern Era: A State-of-Art Focus Review	11
Palliative Care Education in Cardiovascular Disease Fellowships: A National Survey of Program Directors	11
Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese Kyot	11
Time-to-Diuretics in Acute Heart Failure Management: Striking the Balance between “Speed” versus “Accuracy”	11
Evolving Indications, Challenges and Advances in Cardiac Resynchronization Therapy for Heart Failure	11
Standardization of the Right Heart Catheterization and the Emerging Role of Advanced Hemodynamics in Heart Failure	11
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study	10
Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown	10
Masthead	10
Recovering after critical illness – Peter's and Bee's story	10
Patterns And Outcomes Of Covid Positive Donor Utilization For Heart Transplant	10
Long-term Risk of Death and Hospitalization in Patients With Heart Failure and Takotsubo Syndrome: Insights From a Nationwide Cohort	10
Labels of Strategic Intent for LVAD Implantation: “What's in a Name?”	10
Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation	10
Cardiovascular Outcomes Of Levothyroxine Supplementation In Patients With Heart Failure With Reduced Ejection Fraction	10
Comorbidities Associated With Myocarditis In Hospitalized COVID-19 Patients	10
Comparative effectiveness of cardiac resynchronization therapy in older patients with heart failure: Systematic review and meta-analysis	10
Moderate Continuous and Modified High-Intensity Interval Training in Patients With Left Ventricular Assist Devices: The Prospective Train-the-LVAD Trial	10
Overcoming Diagnostic Delays in Pulmonary Hypertension With Deep-Learning ECG Analysis	10
Comparison Of Peripheral Tissue Oxygen Saturation Between Patients With Heart Failure And Controls During A Submaximal Exercise Test: A Pilot Study	10
Transcatheter Aortic Valve Implantation Outcomes Among Recent Mechanical Circulatory Support Recipients	10
Attr Is Underdiagnosed In Aortic Stenosis Despite High Prevalence Of Associated Clinical Conditions	9
Non-invasive Venous Waveform Analysis (niva) Correlates With Pulmonary Capillary Wedge Pressure And Predicts 30-day Admission In Heart Failure Patients Undergoing Right Heart Catheterization	9
Hand Grip Strength Predicts Mortality And Quality Of Life In Heart Failure: Insights From The Singapore Cohort Of Patients With Advanced Heart Failure	9
Racial Differences In The Trends Of Hospitalized Patients With Both Hfref And Hfpef - A National Cohort Analysis	9
Characteristics And Outcomes Of Patients Bridged To Transplant With Iabps Under Exception Status During New Allocation Era	9
Evaluating The Concomitant Therapy Of Sacubitril/ Valsartan And Loop Diuretics In Heart Failure With Reduced Ejection Fraction	9
Electronic-based Characterization And Outcomes Of Heart Failure With Preserved Ejection Fraction	9
Evaluation Of Reduced 30-Day Readmission Rates And Pharmacotherapy Management In Patients Attending Rapid Follow Up Appointments After Hospitalization For Acute Decompensated Heart Failure	9
Cytokine Release Syndrome Mediated Myocarditis: A Rare Complication Of Chimeric Antigen Receptor T-cell Therapy	9
Global Longitudinal Strain Predicts Cardiovascular Events And Future Deterioration In Left Ventricular Ejection Fraction In Patients With Heart Failure With Preserved Ejection Fraction	9
Acetylcholinesterase Inhibitors In Dementia Patients With Heart Failure	9
Ultra-prolonged Intra-aortic Balloon Pump Support Via Sheathless Femoral Access	9
Modelling Lifetime Survival Gain In Patients With Transthyretin Amyloid Cardiomyopathy And Baseline NYHA III: An Analysis Of ATTR-ACT And Long Term Extension Study	9
Transcatheter Repair In Patients With Functional Mitral Regurgitation From The CLASP Study: Outcomes To 2 Years	9
Real-world Experience Of Adverse Events And Modes Of Failure Related To The New Impella 5.5 - A Retrospective Analysis From Manufacturer And User Facility Device Experience Database	9
Effect Of Impella 5.5® On Pre-existing Functional Mitral Regurgitation In Patients With Heart Failure-associated Cardiogenic Shock	9
Safety Of Mechanical Circulatory Support Use For Acute Myocardial Infarction Cardiogenic Shock Among Octogenerians: A Nationwide Cohort Analysis Of United States	9
30-day Readmission Rates In Patients With Premature Heart Failure With Preserved Ejection Fraction	9
Recent Advances in Translational Research for Heart Failure in Japan	8
Impact Of Sarcopenia And Subcutaneous Adipopenia On Outcomes Following Cardiac Resynchronization Therapy	8
Prognostic Impact Of Baseline Six-minute Walk Distance In Patients Receiving TAVR	8
The Outcome Of Acute Heart Failure In Patients With Dementia, A Nationwide Analysis	8
Impact Of Post-Transplant Dialysis On 1-Year Survival After Simultaneous Heart-kidney Transplantation	8
Healthcare Disparities In Advanced Heart Failure Therapies	8
Epsilon Waves And Preventing Sudden Cardiac Death	8
The Outcome Of Acute Heart Failure In Patients With History Of Heart Transplant: A Nationwide Analysis	8
Binding The Brokenhearted Early Recognition Of Depression Improves Heart Failure Patient Outcomes	8
Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth	8
Late-Onset Pembrolizumab Induced Immune Checkpoint Mediated Myocarditis	8
Clinical Characteristics And Outcomes Of Patients With Heart Failure And Reduced Ejection Fraction Who Underwent Chronic Total Occlusion Percutaneous Coronary Revascularization	8
Utility Of The Mayo Clinic Simple Score In Identifying Heart Failure Patients At Low Risk For Underlying ATTR-CM	8
Feasibility Of Outpatient Hemodialysis For Patients With Total Artificial Heart	8
Higher Mortality And Resource Utilization In Patients Undergoing Cardiac Transplantation Affected By Protein-calorie Malnutrition, Nation-Wide Study	8
The Impact Of Pre-heart Transplant Body Mass Index On Long-term Clinical Outcomes According To The Age Distribution	8
The HeartMate 3 Device In Advanced Chronic Kidney Disease	8
Symptomatic Versus Asymptomatic Heartlogic Alerts In The Manage-hf Study	8
Lessons Learned From The Cardiac Amyloidosis Management Program: The Hartford Experience	8
Effect of Premature Ventricular Complexes on Sarcoid Myocarditis: A Nationwide Inpatient Sample analysis	7
Knowledge of Illness Trajectory and Symptoms of Heart Failure in Patients with Acute Coronary Syndrome	7
Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network	7
Cardiac delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs) for treating genetic cardiomyopathies	7
Patient Sex Impacts Volume Phenotypes and Hemodynamics in Chronic Heart Failure: A Multicenter Analysis	7
Right Ventricular Mass Oversizing Is Associated With Improved Post-transplant Survival in Heart Transplant Recipients With Elevated Transpulmonary Gradient	7
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review	7
Socioeconomic Disparities In Temporary Mechanical Circulatory Support Utilization And Revascularization Among Patients Hospitalized For Acute Myocardial Infarct Cardiogenic Shock	7
Structural Heart Failure As A Distinct Group In Acute Decompensated Heart Failure	7
The Future of Durable Mechanical Circulatory Support: Emerging Technological Innovations and Considerations to Enable Evolution of the Field	7
Measuring What Really Matters: A Comparison Of Continuous Ankle Circumference Monitoring And Body Weight In The Management Of Worsening Heart Failure	7
Prevalence, Temporal Change, and Determinants of Anxiety and Depression in Hospitalized Patients With Heart Failure	7
Optimization Protocol To Predict Obstructive Coronary Artery Disease Based On Nuclear Stress Testing	7
Ascending Antibiotic Resistance: A Complex Case Of Implantable Cardioverter Defibrillator Infection In A Patient Awaiting Transplantation	7
ChatGPT Produces Fabricated References and Falsehoods When Used for Scientific Literature Search	7
Case Series: Detection Of Cardiac Allograft Vasculopathy By Vasodilator Stress Myocardial Contrast Echocardiography	7
Echocardiographic Changes At Follow-up In Patients With Myocardial Dysfunction During Acute Coronavirus Disease 2019 (COVID-19) Infection	7
Table of Contents	7
Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy	7
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial	7
Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer	7
Phase 1 Clinical Trial Of TN-301, A Highly Selective HDAC6 Inhibitor With Potential In HFPEF, Shows Target Engagement	7
Levothyroxine Induced Flash Pulmonary Edema	7
Growth Hormone Releasing Hormone Agonist Improves Cardiometabolic Parameters In A Murine Model Of Heart Failure With Preserved Ejection Fraction	7
Contemporary Care and Outcomes of Critically-ill Children With Clinically Diagnosed Myocarditis	7
Novel Translational Animal Model Of Pediatric Viral Myocarditis	7
Online Information, Support And Education - Patient, Caregiver And Clinician Perspectives	7
Lifting and Healing as We Climb: Women's Heart Month	7
Predictive Accuracy Of Heartmate 3 Risk Score After Heart Transplant Allocation Change	6
Not All Bystanders Are Innocent. A Case Of Cardiac Arrest In The Setting Of Type B Aortic Dissection	6
Changes In Prescribing Patterns For Sodium-glucose Cotransporter-2 Inhibitors, An Experience From A Tertiary Care Health System	6
Outcomes Of Heart Failure With Improved Stable Ejection Fraction Vs. Heart Failure With Relapsed Ejection Fraction	6
Sex Differences In Troponin In Covid-19 Patients	6
Stress, Coping, And Quality Of Life In Caregivers Of Patients With Medically Managed Heart Failure, Ventricular Assist Device, Or Cardiac Transplant	6
Global And Country-level Burden Of Heart Failure Secondary To Chagas Disease 1990-2019: An Analysis Of The Global Burden Of Disease Study	6
The HOPE Clinic: More Than Just a Name Change	6